halofantrine has been researched along with d-alpha tocopherol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charman, WN; Khoo, SM; Porter, CJ | 1 |
| Adoro, S; Farombi, EO; Uhunmwangho, S | 1 |
2 other study(ies) available for halofantrine and d-alpha tocopherol
| Article | Year |
|---|---|
The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment.
Topics: Antimalarials; Biological Availability; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Excipients; Gels; Phenanthrenes; Polyethylene Glycols; Solubility; Vitamin E | 2000 |
Antimalarial drugs exacerbate rat liver microsomal lipid peroxidation in the presence of oxidants.
Topics: alpha-Tocopherol; Amodiaquine; Animals; Antimalarials; Antioxidants; Ascorbic Acid; Ferrous Compounds; Hydrogen Peroxide; Lipid Peroxidation; Lipid Peroxides; Liver; Male; Malondialdehyde; Mefloquine; Microsomes, Liver; Oxidants; Phenanthrenes; Rats; Reactive Oxygen Species; Up-Regulation | 2001 |